The Effect of Topical Administration of Common Drugs on Postoperative Bleeding and Pain

Sponsor
St. Olavs Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01964781
Collaborator
(none)
30
1
6
16
1.9

Study Details

Study Description

Brief Summary

After surgical procedures, interventions to reduce postoperative pain and bleeding are of great importance. In this study, the effect will be investigated of smearing common drugs, which are designed for injection, directly onto the raw wound surface (topical application) created during surgery. Topical application allows a small amount of drug to reach a large wound area, higher drug concentration in the exposed wound surface but very low concentration in the body, and no risk of injury from needles. Although beneficial effects of such an easy and low-cost intervention would be expected, the investigators have found no previous reports on blinded and controlled studies.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

The drugs to be studied on whether they reduce bleeding are adrenaline (constricts blood vessels) and tranexamic acid (TXA) (prevents bloodclots from dissolving). The drug studied to what extent it reduces pain will be bupivacaine, a common local anaesthetic. Patients undergoing bilateral symmetric breast surgery or single sided mastectomies are candidates for enrollment in the study. The bilateral patients will have two identical procedures and hence two identical wounds in the same patient. This enables the investigators to use one side as control and hence design our study arms as prospective and placebo-controlled. The patients undergoing a one-sided procedure will need to be compared to similar patients, but as wounds will be of different sizes and in different people, larger groups are needed to find significant differences between treatment and controls.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Effect of Topical Administration of Tranexamic Acid, Adrenaline and Bupivacain on Postoperative Bleeding and Pain in Patients Undergoing Breast Surgery. A Four-armed Placebo-controlled Double Blinded Randomized Study
Actual Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Dec 1, 2014
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: topical tranexamic acid

tranexamic acid to be smeared on surgical wounds before closure

Drug: Tranexamic Acid
Topical administration - does it reduce surgical bleeding?

Experimental: topical adrenaline

adrenaline solution to be smeared on surgical wounds before closure

Drug: Adrenaline
Topical adrenaline - does it reduce bleeding on its own, and does it enhance the effect of tranexamic acid?

Experimental: topical bupivacaine

bupivacaine to be smeared on surgical wounds before closure

Drug: Bupivacaine
Topical Bupivacaine- does it reduce surgical pain?
Other Names:
  • Marcaine
  • Experimental: topical adrenaline plus tranexamic acid

    tranexamic acid and adrenaline to be smeared on surgical wounds before closure

    Drug: Tranexamic Acid
    Topical administration - does it reduce surgical bleeding?

    Drug: Adrenaline
    Topical adrenaline - does it reduce bleeding on its own, and does it enhance the effect of tranexamic acid?

    Placebo Comparator: placebo control

    saline to be smeared on surgical wounds before closure

    Drug: saline

    Placebo Comparator: tranexamic acid and placebo control

    tranexamic acid and saline to be smeared on surgical wounds before closure

    Drug: tranexamic acid plus saline

    Outcome Measures

    Primary Outcome Measures

    1. Amount of blood on drains postoperatively [24 hours postoperatively]

      Drains are placed in surgical wounds during operation, and amount of blood on drains measured in ml on the control after 24 hours.

    2. Amount of pain in operated breast [Measured 24 hours postoperatively]

      Evaluate using a visual analogue scale the pain in the surgical wounds as reported by the patient 24 hours postoperatively

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients undergoing unilateral simple mastectomy

    • patients undergoing bilateral symmetric breast surgery

    Exclusion Criteria:
    • pregnancy

    • A history of former thromboembolic events (to receive TXA)

    • cardiovascular disease (to receive adrenaline)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St Olavs University Hospital Trondheim Norway 7006

    Sponsors and Collaborators

    • St. Olavs Hospital

    Investigators

    • Study Director: Hilde Pleym, MD PhD, St. Olavs Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    St. Olavs Hospital
    ClinicalTrials.gov Identifier:
    NCT01964781
    Other Study ID Numbers:
    • 2012-004964-23
    • 2012-004964-23
    First Posted:
    Oct 17, 2013
    Last Update Posted:
    May 17, 2019
    Last Verified:
    May 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by St. Olavs Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 17, 2019